首页> 美国卫生研究院文献>International Journal of Molecular and Cellular Medicine >Extraction and Identification of Antibacterial Secondary Metabolites from Marine Streptomyces sp. VITBRK2
【2h】

Extraction and Identification of Antibacterial Secondary Metabolites from Marine Streptomyces sp. VITBRK2

机译:海洋链霉菌抗菌二级代谢产物的提取与鉴定。 VITBRK2

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Actinomycetes were isolated from marine sediment samples collected from the east coast of Chennai, Tamil Nadu, India. Well diffusion and agar plug methods were used for the evaluation of antibiotic production by these isolates against drug resistant Methicillin- resistant Staphylococcus aureus (MRSA) and vancomycin resistant Enterococci (VRE). The potential isolate VITBRK2 was mass cultured for morphological and physiological characterization. The culturing conditions of the isolate were optimized and the recommendations of International Streptomyces Project were followed for the assimilation of carbon and nitrogen sources. The isolate was identified by comparing the properties with representative species in the key of Nonomura and Bergey’s Manual of Determinative Bacteriology. Ethyl acetate extract prepared from the cell free culture broth of the isolate was analyzed using HPLC- diode array technique to characterize the metabolites and identify the antibiotics. VITBRK2 was found to be Gram-positive rod grey color aerial mycelium production. It was also non motile in nature with spiral spore chain morphology. VITBRK2 was identified as Streptomyces and designated as Streptomyces sp. VITBRK2. HPLC-DAD analysis showed the presence of indolo compounds (3- methyl-indole and 2-methyl- indole) along with amicoumacin antibiotic. The observed activity of Streptomyces sp. VITBRK2 against MRSA and VRE strains may be due to the presence of indolo compounds in the isolate. The results of this study suggested that secondary metabolites produced by Streptomyces sp. VITBRK2 could be used as a lead to control drug resistant bacterial pathogens.
机译:从印度泰米尔纳德邦钦奈东海岸收集的海洋沉积物样本中分离出放线菌。这些细菌针对耐甲氧西林的金黄色葡萄球菌(MRSA)和耐万古霉素的肠球菌(VRE)的分离株采用良好的扩散和琼脂塞方法评估抗生素的产生。将潜在的分离物VITBRK2进行大量培养,以进行形态学和生理学表征。优化了分离物的培养条件,并遵循国际链霉菌计划的建议来吸收碳和氮源。通过将Nonomura和Bergey的《确定性细菌学手册》中的关键特征与代表性物种进行比较,鉴定出了分离物。从分离物的无细胞培养液中制备的乙酸乙酯提取物使用HPLC-二极管阵列技术进行分析,以表征代谢产物并鉴定抗生素。发现VITBRK2是革兰氏阳性杆灰色气生菌丝体。它在本质上也是非运动的,具有螺旋孢子链形态。 VITBRK2被鉴定为链霉菌并命名为链霉菌。 VITBRK 2。 HPLC-DAD分析显示吲哚类化合物(3-甲基吲哚和2-甲基吲哚)与氨苄青霉素抗生素一起存在。观察到的链霉菌的活性。抗MRSA和VRE菌株的VITBRK2可能是由于分离物中存在吲哚化合物。这项研究的结果表明,链霉菌产生的次级代谢产物。 VITBRK2可用作控制耐药细菌病原体的先导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号